How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case
- 1 June 2017
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 44, 106-116
Abstract
No abstract availableKeywords
Funding Information
- AIRC
This publication has 97 references indexed in Scilit:
- Clinical challenges in the molecular characterization of circulating tumour cells in breast cancerBritish Journal of Cancer, 2013
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Circulating tumour cells in non-metastatic breast cancer: a prospective studyThe Lancet Oncology, 2012
- The Life History of 21 Breast CancersCell, 2012
- Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosisBMC Cancer, 2012
- International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?JNCI: Journal of the National Cancer Institute, 2010
- Tumor Self-Seeding by Circulating Cancer CellsCell, 2009
- Inferring tumor progression from genomic heterogeneityGenome Research, 2009
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapiesBreast Cancer Research and Treatment, 2008
- Systemic Spread Is an Early Step in Breast CancerCancer Cell, 2008